SLC54 Mitochondrial pyruvate carriers in GtoPdb v.2025.3

Tools

Tavoulari, Sotiria and Wilson, Calum (2025) SLC54 Mitochondrial pyruvate carriers in GtoPdb v.2025.3. IUPHAR/BPS Guide to Pharmacology CITE, 2025 (3). ISSN 2633-1020 (https://doi.org/10.2218/gtopdb/F1006/2025.3)

[thumbnail of Tavoulari-Wilson-2025-SLC54-Mitochondrial-pyruvate-carriers-in-GtoPdb]
Preview
 Text. Filename: Tavoulari-Wilson-2025-SLC54-Mitochondrial-pyruvate-carriers-in-GtoPdb.pdf
Final Published Version
License: Creative Commons ShareAlike 4.0 logo
Download (55kB)| Preview

Abstract

The mitochondrial pyruvate carrier (MPC) is composed of SLC54 family members (MPC1 or MPC1L and MPC2) [1, 5, 10], which form functional hetero-dimers [9, 8]. The MPC is expressed in the inner mitochondrial membrane and is responsible for the import of pyruvate into mitochondria [1, 5]. Pyruvate is oxidized to acetyl-CoA by pyruvate dehydrogenase which is localized in the mitochondrial matrix. Ubiquitous disruption of either MPC1 or MPC2 expression results in embryonic lethality [11,12]. Clinically relevant concentrations of the insulin sensitizers, thiazolidinediones, inhibit the MPC [3]. Other clinically relevant inhibitors of the MPC complex are lonidamine [7, 8], quinolone antibacterials [6], entacapone and nitrofurantoin [8].

ORCID iDs

Tavoulari, Sotiria and Wilson, Calum ORCID logoORCID: https://orcid.org/0000-0003-2500-0632;
CORE (COnnecting REpositories)